Search Results

There are 11515 results for: content related to: Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients

  1. You have free access to this content
    Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years old

    American Journal of Hematology

    Volume 90, Issue 7, July 2015, Pages: 639–646, Neha Gupta, Austin Miller, Shipra Gandhi, Laurie A. Ford, Carlos E. Vigil, Elizabeth A. Griffiths, James E. Thompson, Meir Wetzler and Eunice S. Wang

    Version of Record online : 22 JUN 2015, DOI: 10.1002/ajh.24016

  2. Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue 3, September 2014, Pages: 246–254, Kathryn Jackson, Glen Kennedy, Peter Mollee, Paula Marlton and Kirk Morris

    Version of Record online : 27 MAR 2014, DOI: 10.1111/ajco.12188

  3. You have free access to this content
    Clinical and proteomic characterization of acute myeloid leukemia with mutated RAS

    Cancer

    Volume 118, Issue 22, 15 November 2012, Pages: 5550–5559, Tapan M. Kadia, Hagop Kantarjian, Steven Kornblau, Gautam Borthakur, Stefan Faderl, Emil J. Freireich, Raja Luthra, Guillermo Garcia-Manero, Sherry Pierce, Jorge Cortes and Farhad Ravandi

    Version of Record online : 8 MAY 2012, DOI: 10.1002/cncr.27596

  4. You have free access to this content
    Final results of a phase 2 trial of clofarabine and low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia

    Cancer

    Volume 121, Issue 14, July 15 2015, Pages: 2375–2382, Tapan M. Kadia, Stefan Faderl, Farhad Ravandi, Elias Jabbour, Guillermo Garcia-Manero, Gautam Borthakur, Alessandra Ferrajoli, Marina Konopleva, Jan Burger, Xuelin Huang, Xuemei Wang, Sherry Pierce, Mark Brandt, Jennie Feliu, Jorge Cortes and Hagop Kantarjian

    Version of Record online : 25 MAR 2015, DOI: 10.1002/cncr.29367

  5. You have free access to this content
    Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: A report from the Swedish Acute Leukemia Registry

    American Journal of Hematology

    Volume 90, Issue 3, March 2015, Pages: 208–214, Erik Hulegårdh, Christer Nilsson, Vladimir Lazarevic, Hege Garelius, Petar Antunovic, Åsa Rangert Derolf, Lars Möllgård, Bertil Uggla, Lovisa Wennström, Anders Wahlin, Martin Höglund, Gunnar Juliusson, Dick Stockelberg and Sören Lehmann

    Version of Record online : 16 JAN 2015, DOI: 10.1002/ajh.23908

  6. You have free access to this content
    Acute myeloid leukemia: 2014 Update on risk-stratification and management

    American Journal of Hematology

    Volume 89, Issue 11, November 2014, Pages: 1063–1081, Elihu H. Estey

    Version of Record online : 16 OCT 2014, DOI: 10.1002/ajh.23834

  7. Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric oncology patients

    Pediatric Blood & Cancer

    Volume 62, Issue 4, April 2015, Pages: 704–709, Alix E. Seif, Dana M. Walker, Yimei Li, Yuan-Shung V. Huang, Marko Kavcic, Kari Torp, Rochelle Bagatell, Brian T. Fisher and Richard Aplenc

    Version of Record online : 26 MAR 2014, DOI: 10.1002/pbc.25043

  8. You have free access to this content
    Overexpression of lung-resistance protein and increased P-glycoprotein function in acute myeloid leukaemia cells predict a poor response to chemotherapy and reduced patient survival

    British Journal of Haematology

    Volume 103, Issue 4, December 1998, Pages: 1083–1091, Anton G. Borg, Robert Burgess, Linda M. Green, Rik J. Scheper and John A. Liu Yin

    Version of Record online : 4 JAN 2002, DOI: 10.1046/j.1365-2141.1998.01111.x

  9. You have free access to this content
    The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia

    Intervention Review

    The Cochrane Library

    Xi Li, ShuangNian Xu, Ya Tan and JiePing Chen

    Published Online : 3 JUN 2015, DOI: 10.1002/14651858.CD010432.pub2

  10. Reasons for treating secondary AML as de novo AML

    European Journal of Haematology

    Volume 85, Issue 3, September 2010, Pages: 217–226, Lene Sofie Granfeldt Østgård, Eigil Kjeldsen, Mette Skov Holm, Peter De Nully Brown, Bjarne Bach Pedersen, Knud Bendix, Preben Johansen, Jørgen Schøler Kristensen and Jan Maxwell Nørgaard

    Version of Record online : 29 APR 2010, DOI: 10.1111/j.1600-0609.2010.01464.x

  11. You have free access to this content
    Acute myeloid leukemia: 2016 Update on risk-stratification and management

    American Journal of Hematology

    Volume 91, Issue 8, August 2016, Pages: 824–846, Elihu Estey

    Version of Record online : 15 JUL 2016, DOI: 10.1002/ajh.24439

  12. You have free access to this content
    A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of age

    British Journal of Haematology

    Volume 170, Issue 3, August 2015, Pages: 349–355, Sarah A. Buckley, Raya Mawad, Ted A. Gooley, Pamela S. Becker, Vicky Sandhu, Paul Hendrie, Bart L. Scott, Brent L. Wood, Roland B. Walter, Kelly Smith, Carol Dean, Elihu H. Estey and John M. Pagel

    Version of Record online : 8 APR 2015, DOI: 10.1111/bjh.13437

  13. Abstracts of papers presented at the Second Meeting of the European Haematology Association, Paris, France, 29 May-1 June 1996

    British Journal of Haematology

    Volume 93, Issue S2, December 1996, Pages: 1–372,

    Version of Record online : 23 MAR 2012, DOI: 10.1111/j.1365-2141.1996.tb08988.x

  14. You have free access to this content
    Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia

    American Journal of Hematology

    Volume 53, Issue 3, November 1996, Pages: 175–180, Christophe Fruchart, Bernard Lenormand, Christian Bastard, Dominique Boulet, Jean-François Lesesve, Marie-Paule Callat, Aspasla Stamatoullas, Mathleu Monconduit and Herve Tilly

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1096-8652(199611)53:3<175::AID-AJH5>3.0.CO;2-W

  15. Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS

    British Journal of Haematology

    Volume 172, Issue 2, January 2016, Pages: 238–245, Raya Mawad, Pamela S. Becker, Paul Hendrie, Bart Scott, Brent L. Wood, Carol Dean, Vicky Sandhu, Hans Joachim Deeg, Roland Walter, Lixia Wang, Han Myint, Jack W. Singer, Elihu Estey and John M. Pagel

    Version of Record online : 16 NOV 2015, DOI: 10.1111/bjh.13829

  16. You have free access to this content
    Positive selection for CD90 as a purging option in acute myeloid leukemia stem cell transplants

    Cytometry Part B: Clinical Cytometry

    Volume 74B, Issue 1, January 2008, Pages: 9–16, Nicole Feller, Angèle Kelder, Guus Westra, Gert J. Ossenkoppele and Gerrit J. Schuurhuis

    Version of Record online : 5 DEC 2007, DOI: 10.1002/cyto.b.20375

  17. You have free access to this content
    IDA-FLAG (idarubicin, fludarabine, cytarabine, G-CSF), an effective remission-induction therapy for poor-prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: experiences of a phase II trial

    British Journal of Haematology

    Volume 102, Issue 3, August 1998, Pages: 647–655, Fleischhack, Hasan, Graf, Mann and Bode

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2141.1998.00836.x

  18. You have free access to this content
    Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia

    American Journal of Hematology

    Volume 88, Issue 11, November 2013, Pages: 961–966, Aziz Nazha, Hagop Kantarjian, Farhad Ravandi, Xuelin Huang, Sangbum Choi, Guillermo Garcia-Manero, Elias Jabbour, Gautam Borthakur, Tapan Kadia, Marina Konopleva, Jorge Cortes, Alessandra Ferrajoli, Steve Kornblau, Naval Daver, Naveen Pemmaraju, Michael Andreeff, Zeev Estrov, Min Du, Mark Brandt and Stefan Faderl

    Version of Record online : 9 SEP 2013, DOI: 10.1002/ajh.23544

  19. You have free access to this content
    Treatment of children with epipodophyllotoxin-induced secondary acute myeloid leukemia

    Cancer

    Volume 79, Issue 5, 1 March 1997, Pages: 1049–1054, Eric S. Sandler, David J. Friedman, Mahmoud M. Mustafa, Naomi J. Winick, W. Paul Bowman and George R. Buchanan

    Version of Record online : 28 SEP 2000, DOI: 10.1002/(SICI)1097-0142(19970301)79:5<1049::AID-CNCR24>3.0.CO;2-0

  20. You have free access to this content
    Acute myeloid leukemia—Major progress over four decades and glimpses into the future

    American Journal of Hematology

    Volume 91, Issue 1, January 2016, Pages: 131–145, Hagop Kantarjian

    Version of Record online : 23 DEC 2015, DOI: 10.1002/ajh.24246